Targeted inhibition of STATs and IRFs as a novel treatment strategy in cardiovascular disease
2015/17/B/NZ2/00967
Keywords
Descriptors
- NZ2_7: Bioinformatyka
- NZ1_9: Biotechnologia
- NZ1_4: Biologia strukturalna
Panel
NZ2 – Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology
Host institution
Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
prof. Johannes Antonius Bluijssen (Bluyssen)
Number of co-investigators in the project: 6
Call
OPUS 9 – announced on 2015-03-16
- Amount awarded
- 1 206 340 PLN
- Project start date
- 2016-02-08
- Project end date
- 2019-11-07
- Project duration
- 45 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Licencja akademicka PyMol + AxPyMol. Cost: 5 000 PLN
- Pakiet ChemOffice Professional 15 firmy CambridgeSoft. Cost: 3 000 PLN
- Pakiet obliczeniowy Gaussian 09 + GaussView 5.0. Cost: 12 500 PLN
- Real Time PCR - CFX96™ Touch System firmy BioRad.
- Stacja robocza: komputer wieloprocesorowy z monitorem. Cost: 6 000 PLN
- Stacja robocza: komputer wieloprocesorowy z monitorem. Cost: 15 000 PLN
Information in the final report
Publication in academic press/journals (4)
-
Genome-Wide Inhibition of Pro-Atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVD
- Authors:
- Martyna Plens-Galaska, Malgorzata Szelag, Aida Collado, Patrice Marques, Susana Vallejo, Mariella Ramos-González, Joanna Wesoly, Maria Jesus Sanz, Concepción Peiró, Hans A.R. Bluyssen.
- Academic press:
- Frontiers in Immunology (year: 2018, volume: 9, pages: 2141), Publisher: Frontiers
- Status:
- Published
- DOI:
- 10.3389/fimmu.2018.02141 – link to the publication
-
Editorial: STATs and IRFs in Innate Immunity: From Transcriptional Regulators to Therapeutic Targets
- Authors:
- Chien-Kuo Lee and Hans A. R. Bluyssen
- Academic press:
- Frontiers in Immunology (year: 2019, volume: 10, pages: 1829), Publisher: Frontiers
- Status:
- Published
- DOI:
- 10.3389/fimmu.2019.01829 – link to the publication
-
Direct inhibition of IRF-dependent transcriptional regulatory mechanisms associated with disease
- Authors:
- Aleksandra M. Antończyk, Bart Krist, Malgorzata Szelag, Agata Michalska, Anna Piaszyk- Borychowska, Martyna Plens- Galaska, Joanna Wesoly, Hans A. Bluyssen
- Academic press:
- Frontiers in Immunology (year: 2019, volume: 10, pages: 1176), Publisher: Frontiers
- Status:
- Published
- DOI:
- 10.3389/fimmu.2019.01176 – link to the publication
-
Signal Integration of IFN-I and IFN-II with TLR4 involves sequential recruitment of STAT1-complexes and NFκB to enhance pro-inflammatory transcription
- Authors:
- Anna Piaszyk-Borychowska, Lajos Széles, Attila Csermely, Hsin-Chien Chiang, Joanna Wesoły, Chien-Kuo Lee, Laszlo Nagy and Hans A.R. Bluyssen
- Academic press:
- Frontiers in Immunology (year: 2019, volume: 10, pages: 1253), Publisher: Frontiers
- Status:
- Published
- DOI:
- 10.3389/fimmu.2019.01253 – link to the publication
Book publications / chapters in book publications (1)
-
eBook: STATs and IRFs in Innate Immunity: From Transcriptional Regulators to Therapeutic Targets
- Authors:
- editors: Chien-Kuo Lee and Hans A. R. Bluyssen
- Book:
- eBook: STATs and IRFs in Innate Immunity: From Transcriptional Regulators to Therapeutic Targets (year: 2019, volume: n/d, pages: 1-219), Publisher: Frontiers in Immunology
- Status:
- Published